NexGel (NASDAQ:NXGL) Announces Quarterly Earnings Results

NexGel (NASDAQ:NXGLGet Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.08) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.08), Zacks reports. NexGel had a negative return on equity of 49.37% and a negative net margin of 25.02%.

NexGel Price Performance

Shares of NXGL stock traded down $0.11 during trading on Tuesday, hitting $2.28. The company had a trading volume of 142,482 shares, compared to its average volume of 58,309. The firm has a market capitalization of $18.57 million, a P/E ratio of -5.70 and a beta of 0.57. NexGel has a one year low of $2.10 and a one year high of $5.10. The company has a debt-to-equity ratio of 0.16, a quick ratio of 0.98 and a current ratio of 1.74. The stock’s 50-day moving average price is $2.47 and its 200 day moving average price is $2.45.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of NexGel in a report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Sell”.

View Our Latest Research Report on NXGL

About NexGel

(Get Free Report)

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.

Read More

Earnings History for NexGel (NASDAQ:NXGL)

Receive News & Ratings for NexGel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NexGel and related companies with MarketBeat.com's FREE daily email newsletter.